Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.
about
Prognostic value of proliferation in invasive breast cancer: a reviewExpression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breastHidden disease susceptibility and sexual dimorphism in the heterozygous knockout of Cyp51 from cholesterol synthesisRespective prognostic value of genomic grade and histological proliferation markers in early stage (pN0) breast carcinomaAn improved technique for mitosis counting.Distinction between hereditary and sporadic breast cancer on the basis of clinicopathological data.Expression of BNIP3 in invasive breast cancer: correlations with the hypoxic response and clinicopathological featuresProliferation markers in tumours: interpretation and clinical value.Routinely available indicators of prognosis in breast cancer.Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinomaLympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival ratesCurrent breast cancer proliferative markers correlate variably based on decoupled duration of cell cycle phases.A signature inferred from Drosophila mitotic genes predicts survival of breast cancer patientsThe molecular subtype classification is a determinant of sentinel node positivity in early breast carcinomaExternal validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.Mitotic counting in surgical pathology: sampling bias, heterogeneity and statistical uncertainty.Prognostic value of automatically extracted nuclear morphometric features in whole slide images of male breast cancer.Recent advances in the pathology of smooth muscle tumours of the uterus.HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriersLong-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.Prognostic value of mitotic index and Bcl2 expression in male breast cancer.PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.Receptor conversion in distant breast cancer metastasesIntestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDRThe prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.Evaluation of mitotic activity index in breast cancer using whole slide digital images.Demystified...tissue microarray technologyPrognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma.Comparison of Ki-67 equivalent antibodies.Tumour size and vascular invasion predict distant metastasis in stage I breast cancer. Grade distinguishes early and late metastasisMeasuring proliferation in breast cancer: practicalities and applications.Phosphohistone H3 labelling for histoprognostic grading of breast adenocarcinomas and computer-assisted determination of mitotic indexBetter see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds.Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method.MIB-1 labelling index is an independent prognostic marker in primary breast cancer.Oncogene amplification in male breast cancer: analysis by multiplex ligation-dependent probe amplificationPrognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma.
P2860
Q24672660-A467AC6D-5345-4243-9221-F5245D283284Q24813750-748D75C2-A191-46C7-A703-6E0F441DB680Q27326039-C03CE216-9948-4AAA-BAD9-F33E87DEF355Q28730529-E2E0C801-EA66-4C2E-BC04-065CD06D8A69Q31166308-35365074-B5F1-49DF-80E2-C2EF20E8F60FQ33239350-8D44AFA5-0B99-4F72-AFCE-B69E4889BE1DQ33463900-5B16C868-3C44-4D8B-A0BE-10AE7F1FDBD8Q33534215-0B9A5AC1-8A6B-4A77-823A-AE2B7B782155Q33539150-97623DC8-2524-4162-B710-A94C3EBB25C3Q33555247-057CE756-84EA-43DC-85D9-15F13441EDDDQ33557794-3D12C2C8-4B64-477B-87D2-A92E7B63852FQ33595267-1A480ED9-C49F-411B-A4DA-11D22EDC8303Q33687123-35CC1F19-5E97-46C0-A4BC-4F1F94ECA653Q33840749-7D10B83C-29DB-46CF-A94A-A6862AD0FE7FQ33927159-C88461E9-F468-44DA-848D-5420E8B676A1Q34075697-FBB9DDB3-F79E-4052-BCCB-DEBB9E22EC77Q34308865-86011FE4-37C0-4DC8-A988-C38A20688D00Q34382247-F5A517E3-FBF4-44CF-990E-AFB02FF488E7Q34421547-8C581AAA-B0B0-4364-BD39-621F82C61180Q34586591-6105CB1A-FF5C-4A5C-B104-63B775F1DED9Q34633934-05C74FF5-A8CD-4132-B368-3698A099AAD3Q34661870-7B1C7F6F-958E-4BE2-9CB9-69088324B6DFQ34776179-998E9BA1-92FB-488E-855F-F6A62B61016AQ34989060-2DD301FA-3D10-43B6-B9C0-4253EAB38230Q35000531-5E937040-0033-4445-88EA-4EA4F0A5114FQ35064038-F9352145-E275-41CE-8C5D-A8D857E65216Q35080019-9B62CE9B-12C1-4E9F-9B3F-E6FC92ACE0E4Q35188716-A4FB195D-CEAF-4290-9370-CF962A8D4A80Q35399269-6EA6D6A8-4D3C-4813-9F9E-F6523D09A4A6Q35585987-DDA60BCE-E67A-4DCC-96D6-8DBAE25F0DD5Q35586210-BD5197F1-27BF-4C24-BA32-70516560F7C4Q35588322-EE947045-2F39-43D4-8FEF-984B670E66BCQ35633693-1EB440DD-6C8A-4D3A-A24E-F61AD0FA5EB9Q35770098-DFA4FBE8-7DCA-4CC7-B8E7-DDE0651028DFQ35788622-C43FF94E-31F9-411D-BF78-A48896C57046Q35853860-255ACFBE-39EF-4B84-891E-8C44A9916768Q36105024-5590BEF8-F9FB-4AD4-B8F9-502D0AAF0BCEQ36115384-8FA3631F-1542-461F-BB94-9C9E305E1909Q36147178-D4FD4DBB-26BD-43A2-9832-1A5A31C971E2Q36295045-1AB6A1C2-18BA-4E9D-AC9E-6282D6B25E53
P2860
Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@en
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@nl
type
label
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@en
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@nl
prefLabel
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@en
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@nl
P2093
P1433
P1476
Reproducibility of mitosis cou ...... ric Mammary Carcinoma Project.
@en
P2093
C M van Galen
E C Wisse-Brekelmans
J Fijnheer
L H van Gorp
P H Kurver
P J van Diest
P Matze-Cok
S M Bellot
P304
P356
10.1016/0046-8177(92)90313-R
P407
P577
1992-06-01T00:00:00Z